Enveric Biosciences, Inc.
ENVB· Nasdaq
Filed Mar 7, 2012 · 10-K · 67 days after period end · 0001477932-12-000619
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$14.98K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 7, 2012 · 67 d after period end